189P - Are pretreatment neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and advanced lung cancer inflamation index (ALI) levels useful in predicting the outcomes of patients with advanced non-small cell lung cancer?
Authors
- Berna Komurcuoglu (TR)
- Aysen Evkan (TR)
- Gamze Karakurt (TR)
Presenter
- Berna Komurcuoglu (TR)
20P - ArgSS1 expression in squamous cell carcinoma of the lung
Authors
- Elizabeth Cathcart-Rake (US)
- Anja Roden (US)
- Aaron Mansfield (US)
Presenter
- Elizabeth Cathcart-Rake (US)
4P - Assessment of PD-L1 expression by immunohistochemistry in histological and cytological non-small cell lung carcinoma (NSCLC) in the era of immunotherapy: A national Irish study
Authors
- Aurelie Fabre (IE)
- Katie Breen (IE)
- Janet McCormack (IE)
Presenter
- Aurelie Fabre (IE)
87P - Assessment of the prognostic utility of the enumeration of circulating tumour cells at the end of treatment and disease relapse in small cell lung cancer patients
Authors
- Alexander J. Vickers (GB)
- Andreas Xenofontos (GB)
- Louise Carter (GB)
- Reyes Bernabe (ES)
- Matthew Carter (GB)
- Lynsey Franklin (GB)
- Karen Morris (GB)
- Jacqueline Pierce (GB)
- Caroline Dive (GB)
- Fiona Blackhall (GB)
Presenter
- Alexander J. Vickers (GB)
125P - Brain metastases in patients with stage N2 non-small cell lung cancer
Authors
- Caroline Lowrie (GB)
- Elisabeth McCully (GB)
- Sonam Ansel (GB)
- Philip McLoone (GB)
- Nazia Mohammed (GB)
Presenter
- Caroline Lowrie (GB)
124P - Cardiac events in stage III non-small cell lung cancer (NSCLC): An attention shift to cardio-oncology collaboration
Authors
- Juliette Degens (NL)
- Dirk De Ruysscher (NL)
- Bas Kietselaer (NL)
- Annemie Schols (NL)
- Anne-Marie C. Dingemans (NL)
Presenter
- Juliette Degens (NL)
196TiP - CheckMate 384: A phase 3b/4 dose-frequency optimization trial of nivolumab in advanced or metastatic NSCLC
Authors
- Edward B. Garon (US)
- Niels Reinmuth (DE)
- Ronald Harris (US)
- Paul Mitchell (AU)
- Jin Zhu (US)
- Giovanni Selvaggi (US)
- Shruti Agrawal (US)
- Eric Pichon (FR)
Presenter
- Edward B. Garon (US)
12P - Cigarette smoke promotes proliferation of non-small cell lung cancer (NSCLC) via enhancing glucose uptake and glycolysis
Authors
- I-Shan Hsieh (TW)
- Fang-Ju Cheng (TW)
- Chih-Yen Tu (TW)
- Chia-Hung Chen (TW)
- Te-Chun Hsia (TW)
- Bo-Wei Wang (TW)
- Yi-Lun Yeh (TW)
- Wei-Chien Huang (TW)
Presenter
- I-Shan Hsieh (TW)
59P - Circulating microRNAs as novel predictive markers of afatinib efficacy in squamous cell lung cancer (SCC): An exploratory sub-analysis of the LUX-Lung 8 trial
Authors
- Yann Gaston Math_ (FR)
- Paul Fogel (FR)
- Séverine Martin-Lannerée (FR)
- Charles Marcaillou (FR)
- Elodie Lallet (FR)
- Nicole Krämer (DE)
- Neil Gibson (NA)
- Flavio Solca (AT)
- Eva Ehrnrooth (DK)
- Jacques Cadranel (FR)
Presenter
- Yann Gaston Math_ (FR)
60P - Circulating miR-31 as a predictive marker of EGFR TKI treatment efficacy in squamous cell lung cancer (SCC): A sub-analysis of the LUX-Lung 8 trial
Authors
- Yann Gaston Math_ (FR)
- Paul Fogel (FR)
- Séverine Martin-Lannerée (FR)
- Charles Marcaillou (FR)
- Elodie Lallet (FR)
- Nicole Krämer (DE)
- Neil Gibson (NA)
- Flavio Solca (AT)
- Eva Ehrnrooth (DK)
- Jacques Cadranel (FR)
Presenter
- Yann Gaston Math_ (FR)
64P - Cisplatin-resistant phenotype: Characterization, adaptation to EGFR signaling and sensitivity to EGFR inhibitors in NSCLC cells
Authors
- Venu Pamidiboina (DE)
- Fei Tian (DE)
- Rosemarie Kiefl (DE)
- Marina Schaule (DE)
- Rudolf Maria Huber (DE)
Presenter
- Venu Pamidiboina (DE)
119P - Cisplatin/etoposide or paclitaxel/carboplatin with concurrent radiation therapy in stage IIIB non-small cell lung cancer: A one-year phase II trial at a low resource setting
Authors
- Md Shuayb (BD)
- Md S. Shahi (BD)
- Md M. Hossen (BD)
Presenter
- Md Shuayb (BD)